Tag: Boston
Roivant Sciences to acquire Silicon Therapeutics to boost drug discovery capabilities
Roivant Sciences has agreed to acquire Silicon Therapeutics, a Boston-based drug design, research, and development company, for $450 million, in an all-share deal. The Swiss ... Read More
HUB International acquires Baystate Fiduciary Advisors in Boston
HUB International, a global insurance brokerage, has acquired the assets of Baystate Fiduciary Advisors based in Boston, Massachusetts for an undisclosed price. Baystate Fiduciary Advisors ... Read More
Snow Phipps acquires rapid prototyping company Prototek
Private equity firm Snow Phipps Group has closed its acquisition of Prototek, a US-based rapid prototyping services provider of CNC machined and sheet metal fabricated ... Read More
InnovHeart raises €20m for TMVR systems for mitral valve disease
InnovHeart, an Italian medical device manufacturer, has raised €20 million in a Series B funding round for its transcatheter mitral valve replacement systems (TMVR systems) ... Read More
Israel-based Sapiens acquires US insurtech company Delphi Technology
Sapiens acquisition of Delphi Technology : Israel-based Sapiens International has acquired US insurtech company Delphi Technology for $19.5 million in an all-cash deal in a ... Read More
Novo Nordisk to acquire cardio-renal disease company Corvidia Therapeutics
Novo Nordisk acquisition of Corvidia : Danish pharma company Novo Nordisk has agreed to acquire Corvidia Therapeutics from life sciences venture capital firm Sofinnova Partners ... Read More
JLL Income Property Trust buys Milford Crossing shopping center near Boston
JLL Income Property Trust has purchased the newly-built Milford Crossing shopping center in Milford, Massachusetts for about $42 million. According to the real estate investment ... Read More
AstraZeneca taps into Gatehouse Bio’s sRNAlytics AI platform for drug discovery
US biodata company Gatehouse Bio is joining forces with pharma giant AstraZeneca to accelerate the discovery of new drugs for respiratory and cardiovascular diseases using ... Read More
Alkermes to acquire Boston-based neuroscience company Rodin Therapeutics
Alkermes acquisition of Rodin Therapeutics : Irish biopharma company Alkermes has agreed to acquire Boston-based neuroscience company Rodin Therapeutics in a deal worth up to ... Read More
ProTom Radiance 330 proton therapy system bags FDA 510(k) Clearance
ProTom International has been given 510(k) clearance from the US Food and Drug Administration (FDA) for its Radiance 330 proton therapy system installed at the ... Read More